Company Registration No. 8681617 (England and Wales)
Renaclinical Limited
Unaudited accounts
for the year ended 31 October 2020
Renaclinical Limited
Unaudited accounts
Contents
Renaclinical Limited
Company Information
for the year ended 31 October 2020
Directors
Ka Yan Che
Peter Mollison
Company Number
8681617 (England and Wales)
Registered Office
Unit 11 Gatwick Metro Centre
Balcombe Road
Horley
RH6 9GA
Accountants
Vincent Lim
70 Dowdeswell Close
London
SW15 5RL
Renaclinical Limited
Statement of financial position
as at 31 October 2020
Tangible assets
315,324
89,732
Cash at bank and in hand
462,445
239,587
Creditors: amounts falling due within one year
(35,153)
(17,844)
Net current assets
519,574
308,606
Net assets
834,898
398,338
Called up share capital
1,000
1,000
Profit and loss account
833,898
397,338
Shareholders' funds
834,898
398,338
For the year ending 31 October 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 2 July 2021 and were signed on its behalf by
Ka Yan Che
Director
Company Registration No. 8681617
Renaclinical Limited
Notes to the Accounts
for the year ended 31 October 2020
Renaclinical Limited is a private company, limited by shares, registered in England and Wales, registration number 8681617. The registered office is Unit 11 Gatwick Metro Centre, Balcombe Road, Horley, RH6 9GA.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover represents the value, net of VAT and discounts, of goods provided to customers and work carried out in respect of services provided to customers.
Tangible fixed assets policy
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Land & buildings
Plant & machinery
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At cost
At cost
At 1 November 2019
8,663
103,907
5,953
3,450
121,973
Additions
-
306,801
-
6,211
313,012
At 31 October 2020
8,663
410,708
5,953
9,661
434,985
At 1 November 2019
2,486
24,494
2,382
2,879
32,241
Charge for the year
1,733
82,141
1,191
2,355
87,420
At 31 October 2020
4,219
106,635
3,573
5,234
119,661
At 31 October 2020
4,444
304,073
2,380
4,427
315,324
At 31 October 2019
6,177
79,413
3,571
571
89,732
Renaclinical Limited
Notes to the Accounts
for the year ended 31 October 2020
5
Debtors: amounts falling due within one year
2020
2019
Trade debtors
80,032
70,341
Accrued income and prepayments
-
850
Other debtors
12,250
12,250
6
Creditors: amounts falling due within one year
2020
2019
Trade creditors
11,337
420
Taxes and social security
6,075
14,840
Other creditors
17,741
2,584
Allotted, called up and fully paid:
1,000 Ordinary shares of £1 each
1,000
1,000
8
Average number of employees
During the year the average number of employees was 10 (2019: 4).
